Role of Extended Spectrum Beta Lactamases in Cephalosporin and Carbapenem Resistance in Escherichia coli from Inpatients and Outpatients in Nigeria

Introduction: Antimicrobial resistance requires global coordinated action with a view to addressing its rising threat. Prevalence of antimicrobial resistance has been increasing worldwide in both developed and developing countries. Whilst cephalosporin and carbapenem resistance is a problem in Esche...

Full description

Bibliographic Details
Main Authors: Akinwale Majeed Akinlabi, Afolabi Oluwadun, Oyebode Armstrong Terry Alli, Adeolu Sunday Oluremi, Mark A Webber, David Olusoga Ogbolu
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2020-02-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/13515/43328_F(SL)_PF1(AG_SHU)_PFA(KM)_PB(AG_KM)_PN(SL).pdf
_version_ 1818579239381762048
author Akinwale Majeed Akinlabi
Afolabi Oluwadun
Oyebode Armstrong Terry Alli
Adeolu Sunday Oluremi
Mark A Webber
David Olusoga Ogbolu
author_facet Akinwale Majeed Akinlabi
Afolabi Oluwadun
Oyebode Armstrong Terry Alli
Adeolu Sunday Oluremi
Mark A Webber
David Olusoga Ogbolu
author_sort Akinwale Majeed Akinlabi
collection DOAJ
description Introduction: Antimicrobial resistance requires global coordinated action with a view to addressing its rising threat. Prevalence of antimicrobial resistance has been increasing worldwide in both developed and developing countries. Whilst cephalosporin and carbapenem resistance is a problem in Escherichia coli in Nigeria, there is a paucity of information regarding the mechanisms of resistance underpinning this in prevalence and types of extended spectrum in clinical E. coli. Aim: To detect and characterise Extended Spectrum β Lactamases (ESBL) in clinical E. coli from inpatients and outpatients in Nigeria. Materials and Methods: A total of 104 E. coli were obtained from 498 non-duplicate clinical specimens from Northern Nigeria between November 2017 and November 2018. Antibiotic susceptibility of third generation cephalosporin including other important antibiotics and phenotypic detection of ESBL of the isolates were determined. Genotypic detection of ESBL and randomly amplified polymorphic DNA to determine clonality were used to further characterise 44 E. coli isolates selected based on their phenotypes and clinical specimens. The data were analysed with the aid of statistical package for social sciences (IBM SPSS), version 21.0 and were reported in frequency tables and in percentages. Results: Majority of the E. coli isolates showed no clonal relationships. More than half of E. coli were resistant to third generation cephalosporin class of antibiotics. There was no difference between MIC50 and MIC90 values for the majority isolates for most drugs where MICs ≥256 µg/mL were the norm except for carbapenems with low level resistance. In total, 44/104 (42.3%) E. coli were ESBL producers. blaCTX-M was the dominant ESBLs seen in 75% (33/44) of isolates, of these blaCTX-M-15 variant was most common and seen in 72.7% (24/33) of isolates followed by blaVEB, 21/44 (47.7%) and blaPER 6/44 (13.6%). No AmpC or carbapenemase genes were identified. Conclusion: E. coli isolates from Northern Nigeria are highly multi-drug resistant with only carbapenems of common therapeutic drug classes retaining significant activity. Betalactam resistance is largely underpinned by carriage of CTX-M15 and carbapenem resistance is likely to be a result of ESBL carriage with other mechanisms.
first_indexed 2024-12-16T06:58:32Z
format Article
id doaj.art-ba488945c9af4b379cadca8ba650a71e
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-16T06:58:32Z
publishDate 2020-02-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-ba488945c9af4b379cadca8ba650a71e2022-12-21T22:40:14ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2020-02-01142DC10DC1510.7860/JCDR/2020/43328.13515Role of Extended Spectrum Beta Lactamases in Cephalosporin and Carbapenem Resistance in Escherichia coli from Inpatients and Outpatients in NigeriaAkinwale Majeed Akinlabi0Afolabi Oluwadun1Oyebode Armstrong Terry Alli2Adeolu Sunday Oluremi3Mark A Webber4David Olusoga Ogbolu5Research Assistant, Department of Medical Microbiology and Parasitology, Olabisi Onabanjo University, Ago-Iwoye, Ogun, Nigeria.Professor, Department of Medical Microbiology and Parasitology, Olabisi Onabanjo University, Ago-Iwoye, Ogun, Nigeria.Professor, Department of Biomedical Science, Ladoke Akintola University of Technology, Ogbomoso, Oyo, Nigeria.Research Assistant, Department of Biomedical Science, Ladoke Akintola University of Technology, Ogbomoso, Oyo, Nigeria.Research Group Leader, Department of Microbes in the Food Chain, Quadram Institute Bioscience, Norwich, England, United Kingdom.Reader, Department of Biomedical Science, Ladoke Akintola University of Technology, Ogbomoso, Oyo, Nigeria.Introduction: Antimicrobial resistance requires global coordinated action with a view to addressing its rising threat. Prevalence of antimicrobial resistance has been increasing worldwide in both developed and developing countries. Whilst cephalosporin and carbapenem resistance is a problem in Escherichia coli in Nigeria, there is a paucity of information regarding the mechanisms of resistance underpinning this in prevalence and types of extended spectrum in clinical E. coli. Aim: To detect and characterise Extended Spectrum β Lactamases (ESBL) in clinical E. coli from inpatients and outpatients in Nigeria. Materials and Methods: A total of 104 E. coli were obtained from 498 non-duplicate clinical specimens from Northern Nigeria between November 2017 and November 2018. Antibiotic susceptibility of third generation cephalosporin including other important antibiotics and phenotypic detection of ESBL of the isolates were determined. Genotypic detection of ESBL and randomly amplified polymorphic DNA to determine clonality were used to further characterise 44 E. coli isolates selected based on their phenotypes and clinical specimens. The data were analysed with the aid of statistical package for social sciences (IBM SPSS), version 21.0 and were reported in frequency tables and in percentages. Results: Majority of the E. coli isolates showed no clonal relationships. More than half of E. coli were resistant to third generation cephalosporin class of antibiotics. There was no difference between MIC50 and MIC90 values for the majority isolates for most drugs where MICs ≥256 µg/mL were the norm except for carbapenems with low level resistance. In total, 44/104 (42.3%) E. coli were ESBL producers. blaCTX-M was the dominant ESBLs seen in 75% (33/44) of isolates, of these blaCTX-M-15 variant was most common and seen in 72.7% (24/33) of isolates followed by blaVEB, 21/44 (47.7%) and blaPER 6/44 (13.6%). No AmpC or carbapenemase genes were identified. Conclusion: E. coli isolates from Northern Nigeria are highly multi-drug resistant with only carbapenems of common therapeutic drug classes retaining significant activity. Betalactam resistance is largely underpinned by carriage of CTX-M15 and carbapenem resistance is likely to be a result of ESBL carriage with other mechanisms.https://jcdr.net/articles/PDF/13515/43328_F(SL)_PF1(AG_SHU)_PFA(KM)_PB(AG_KM)_PN(SL).pdfantibioticsbacteriainfectionsresistance genes
spellingShingle Akinwale Majeed Akinlabi
Afolabi Oluwadun
Oyebode Armstrong Terry Alli
Adeolu Sunday Oluremi
Mark A Webber
David Olusoga Ogbolu
Role of Extended Spectrum Beta Lactamases in Cephalosporin and Carbapenem Resistance in Escherichia coli from Inpatients and Outpatients in Nigeria
Journal of Clinical and Diagnostic Research
antibiotics
bacteria
infections
resistance genes
title Role of Extended Spectrum Beta Lactamases in Cephalosporin and Carbapenem Resistance in Escherichia coli from Inpatients and Outpatients in Nigeria
title_full Role of Extended Spectrum Beta Lactamases in Cephalosporin and Carbapenem Resistance in Escherichia coli from Inpatients and Outpatients in Nigeria
title_fullStr Role of Extended Spectrum Beta Lactamases in Cephalosporin and Carbapenem Resistance in Escherichia coli from Inpatients and Outpatients in Nigeria
title_full_unstemmed Role of Extended Spectrum Beta Lactamases in Cephalosporin and Carbapenem Resistance in Escherichia coli from Inpatients and Outpatients in Nigeria
title_short Role of Extended Spectrum Beta Lactamases in Cephalosporin and Carbapenem Resistance in Escherichia coli from Inpatients and Outpatients in Nigeria
title_sort role of extended spectrum beta lactamases in cephalosporin and carbapenem resistance in escherichia coli from inpatients and outpatients in nigeria
topic antibiotics
bacteria
infections
resistance genes
url https://jcdr.net/articles/PDF/13515/43328_F(SL)_PF1(AG_SHU)_PFA(KM)_PB(AG_KM)_PN(SL).pdf
work_keys_str_mv AT akinwalemajeedakinlabi roleofextendedspectrumbetalactamasesincephalosporinandcarbapenemresistanceinescherichiacolifrominpatientsandoutpatientsinnigeria
AT afolabioluwadun roleofextendedspectrumbetalactamasesincephalosporinandcarbapenemresistanceinescherichiacolifrominpatientsandoutpatientsinnigeria
AT oyebodearmstrongterryalli roleofextendedspectrumbetalactamasesincephalosporinandcarbapenemresistanceinescherichiacolifrominpatientsandoutpatientsinnigeria
AT adeolusundayoluremi roleofextendedspectrumbetalactamasesincephalosporinandcarbapenemresistanceinescherichiacolifrominpatientsandoutpatientsinnigeria
AT markawebber roleofextendedspectrumbetalactamasesincephalosporinandcarbapenemresistanceinescherichiacolifrominpatientsandoutpatientsinnigeria
AT davidolusogaogbolu roleofextendedspectrumbetalactamasesincephalosporinandcarbapenemresistanceinescherichiacolifrominpatientsandoutpatientsinnigeria